Q2 2023 MDxHealth SA Earnings Call Transcript
Greetings, and welcome to MDxHealth 2023 Q2 and mid-year earnings call. (Operator Instructions) As a reminder, this conference is being recorded.
Before we begin, I would like to remind everyone that we will make forward-looking statements during today's call, whether in prepared remarks or during the Q&A session. These forward-looking statements are subject to inherent risks and uncertainties. These risks and uncertainties are detailed in the risk factors section of our filings with the Securities and Exchange Commission, specifically in the company's annual report on Form 20-F.
It is now my pleasure to introduce Michael McGarrity, Chief Executive Officer. Thank you. You may begin.
Thanks, Doug. And thank you all for joining us for our 2023 Q2 and mid-year earnings conference call for MDxHealth. With me today is Ron Kalfus, Chief Financial Officer.
Following our strong first-quarter results, our second-quarter results further reflect our commitment to all stakeholders to delivering strong
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |